EPC2407

· EpiCept Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EPC2407, covering 2009-09-10 to 2009-09-10. Get the full timeline:

Most recent: Clinical Trial Update: A Safety Study of EPC2407, A Anti-Cancer Drug With Vascular Disrupting Activity: In Patients With Advanced Cancer [Phase 1]

See pricing